| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2143799 | Lung Cancer | 2007 | 6 Pages |
Abstract
Isolated nodal recurrence following PET-staged I NSCLC treated with SBRT is uncommon. Moderate post-SBRT PET hypermetabolic activity may persist 2 years following treatment without definite evidence of recurrence. Further study is needed to confirm these results in larger populations with longer follow-up.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
David J. Hoopes, Mark Tann, James W. Fletcher, Jeffrey A. Forquer, Pei-Fen Lin, Simon S. Lo, Robert D. Timmerman, Ronald C. McGarry,